1. Home
  2. INGN vs ALEC Comparison

INGN vs ALEC Comparison

Compare INGN & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.31

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$1.51

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGN
ALEC
Founded
2001
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
158.8M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
INGN
ALEC
Price
$6.31
$1.51
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$11.25
$4.83
AVG Volume (30 Days)
195.1K
518.5K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
N/A
EPS
N/A
N/A
Revenue
$348,668,000.00
$21,045,000.00
Revenue This Year
$8.03
$2.03
Revenue Next Year
$7.76
$29.87
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$1.09
52 Week High
$9.13
$3.40

Technical Indicators

Market Signals
Indicator
INGN
ALEC
Relative Strength Index (RSI) 48.07 41.58
Support Level $6.00 $1.37
Resistance Level $6.73 $1.60
Average True Range (ATR) 0.24 0.12
MACD -0.03 -0.00
Stochastic Oscillator 41.79 25.44

Price Performance

Historical Comparison
INGN
ALEC

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: